Ranbaxy launches injectable antibiotic, eyes Rs 150 cr-mkt
Pharma major Ranbaxy Laboratories Limited (RLL) launched a high-end injectable antibiotic under the brand name Cilanem, eyeing the Rs 150-crore market in the country. The city-based drugmaker said